Biotechnology Flashcards

1
Q

Define biologics

A

Any virus, therapeutic serum, toxin, antitoxin, used in the prevention, treatment or cure of diseases in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are small molecules developed?

A

Through high throughput SCREENING.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are biologics developed? Steps?

A

CONSTRUCT instead of screen
1.choose a target
2. Construct biologic candidates
3. Experimental testing
4. Clinical trials

Development, Validation, Manufacture, Formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When is Q5D and Q5E quality control used

A

Q5D
- used when deriving new substrates for biotechnology purposes

Q5E
- used when making biosimilars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 enzymatic regulatory activity?

A
  1. Replacement of deficient/abnormal proteins
  2. Augment existing pathways
  3. Novel function or activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

enzymatic regulatory activity:
What do we use replacement of deficient/abnormal proteins for? (3)

A

a. hormone deficiencies:
- insulin, genotropic for (hGH deficiencies)

b. Hemostasis, thrombosis;
- clotting factors (8, 7a)

c. Gi disorders
- lactaid
- pancreatic enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

enzymatic regulatory activity:
How do we augment existing pathways?

A

a. Anemia
- augment the erythropoiesis pathway

b. Immunoregulation:
- produce WBCs, platelets, and modulate immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

enzymatic regulatory activity
How do we use novel function/activity?

A

a. Degrade existing molecules
- disrupt neuromuscular junction, lung mucus viscosity reduction

b. hemostasis, thrombosis
- produce anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In special targeting activity:
How do we interfere with molecule/organism

A

a. Prevent infectious diseases
- Stop HIV entry

B. Cancer
- bind surface receptors of cancer cells

c. Immunoregulation
- Bind TNF, prevent inflammatory cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In special targeting activity:
How do we deliver molecules

A

Cancer
- deliver cytotoxic agents to cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What type of cells produce antibodies?

A

B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the structure of antibodies? Fc vs Fab

A

Large Y shape
4 protein chains connected by disulfide bonds

Fc (crystallisable) = constant region
Fab (antigen binding) = variable region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do hypervariable regions in FAB work?

A

Target specific parts of antigens in a “lock and key”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define polyclonal antibodies

A

generated from an Immune response to an antigen
- Different B cell receptors produce a range of antibodies
- multiple lineages of B cells = polyclonal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define monoclonal antibodies

A

single line of B cells, selected to produce the SAME antibodies (-mab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In humanization of antibodies define
Chimeric
Humanized
Human

A

FC region from mice leads to shorter half life, less immune response, inefficient effect

  • Chimeric: Human FC + mouse-derived FAB (variable) region -OMAB
    • Bad for half life, immune response
  • Humanized: human Ab + mouse CDR -IMAB
  • Human: no mouse genetic sequences -ZUMAB
17
Q

Define antibody drug conjugates
Characterisitics?

A

Small molecule is attached to mAB to make use of its specificity
- can be cleavable, non-cleavable
- Attachment site can be Fc or FAB

18
Q

What do the following excipients do to aid stability/delivery

Salts
Surfactants
Buffers
Cyclodesxtrins
Polyalcohols
PEG

A

Salts
- decrease denaturation, aggregation

Surfactants
- prevent adsorption of proteins

Buffers
- maintenance of pH

Cyclodesxtrins
- decrease aggregation

Polyalcohols
- stabilize, maintain isotonicity

PEG: INCREASE HALF LIFE OF PROTEINS DRUGS

19
Q

Describe lyophilization. Issue?

A

“freeze drying”
- remove water from product –> form dry powder. Good for long-term storage

Issue: protein aggregation
- stabilizers (sucrose)
- Surfactants
- DO NOT SHAKE

20
Q

What is Q5C
Define potency and purity in this

A

Q5C
- stability testing of biotechnological/biological products

Potency: ability of a product to achieve its intended effect
Purity: relative, dependant on the product

21
Q

Which protein takes the longest to develop in vaccines? quickest?

A

Longest: protein VLP
quickest: mRNA

22
Q

Define antisense gene therapy

A

Antisense RNA binds to sense sequence to block protein synthesis

23
Q

Define cell therapy

Vivo cell therapy?
Allogenic cell therapy?

A

Using THE WHOLE CELL to bring effect
* Blood transfusions, bone marrow transplants, stem cells for regenerative medicine

Ex vivo cell therapy: modifying the patients OWN cells but OUTSIDE the body

Allogenic cell therapy: using cells from a DONOR

24
Q

Differentiate between somatic cells and germline cells in genome editing

A

Changes to somatic cells are not passed on to offspring,
Changes to germline cells are passed to offspring

25
Q

What does CRISPR stand for? Cas9?

A

CRISPR = Clustered regularly interspaced short palindromic repeats

Crispr associated system